- Home
- VACH vs ALDX Comparison
VACH vs ALDX Comparison
Compare VACH & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VACH
- ALDX
- Stock Information
- Founded
- VACH 2023
- ALDX 2004
- Country
- VACH United States
- ALDX United States
- Employees
- VACH N/A
- ALDX N/A
- Industry
- VACH
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- VACH
- ALDX Health Care
- Exchange
- VACH NYSE
- ALDX Nasdaq
- Market Cap
- VACH 324.2M
- ALDX 133.7M
- IPO Year
- VACH 2024
- ALDX 2014
- Fundamental
- Price
- VACH $10.29
- ALDX $2.16
- Analyst Decision
- VACH
- ALDX Strong Buy
- Analyst Count
- VACH 0
- ALDX 2
- Target Price
- VACH N/A
- ALDX $9.50
- AVG Volume (30 Days)
- VACH 177.1K
- ALDX 1.5M
- Earning Date
- VACH 01-01-0001
- ALDX 05-20-2025
- Dividend Yield
- VACH N/A
- ALDX N/A
- EPS Growth
- VACH N/A
- ALDX N/A
- EPS
- VACH 0.26
- ALDX N/A
- Revenue
- VACH N/A
- ALDX N/A
- Revenue This Year
- VACH N/A
- ALDX N/A
- Revenue Next Year
- VACH N/A
- ALDX N/A
- P/E Ratio
- VACH $40.05
- ALDX N/A
- Revenue Growth
- VACH N/A
- ALDX N/A
- 52 Week Low
- VACH $9.95
- ALDX $1.14
- 52 Week High
- VACH $11.20
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- VACH N/A
- ALDX 34.82
- Support Level
- VACH N/A
- ALDX $1.90
- Resistance Level
- VACH N/A
- ALDX $2.89
- Average True Range (ATR)
- VACH 0.00
- ALDX 0.23
- MACD
- VACH 0.00
- ALDX 0.10
- Stochastic Oscillator
- VACH 0.00
- ALDX 26.26
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.